Sophia Zoungas
Sophia Zoungas is a clinical endocrinologist from Victoria, Australia. She is recognised for her work in the management of diabetes and its vascular complications and leads Australia's largest translational research program in diabetes care and benchmarking of diabetes services. Zoungas's research explores the link between diabetes, glucose levels and cardiovascular risks and has enabled people with diabetes to be prescribed medication that reduce their cardiovascular risk factors. She is head of the School of Public Health and Preventative Medicine at Monash University and is the Professor of Diabetes, Vascular Health and Ageing and is also deputy director of Research at Alfred Health.In 2022 Zoungas was elected as a fellow of the Australian Academy of Health and Medical Sciences and in the same year was awarded the Kellion Award from the Australian Diabetes Society. Provided by Wikipedia
Showing 1 - 10 results of 10 for search 'Sophia Zoungas', query time: 0.43s
Refine Results
-
1
-
2
-
3
-
4
Development, Relative Validity and Reproducibility of the Aus-SDS (Australian Short Dietary Screener) in Adults Aged 70 Years and above by Adelle M. Gadowski, Tracy A. McCaffrey, Stephane Heritier, Andrea J. Curtis, Natalie Nanayakkara, Sophia Zoungas, Alice J. Owen
Published 2020-05-01
Article -
5
Immune checkpoint inhibitors and the risk of major atherosclerotic cardiovascular events in patients with high-risk or advanced melanoma: a retrospective cohort study by Charlie Wang, Sophia Zoungas, Mabel Yan, Rory Wolfe, Andrew Haydon, Mark Shackleton, Mark Voskoboynik, Maggie Moore, Miles C. Andrews, Stephen J. Nicholls, Victoria Mar
Published 2022-12-01
Article -
6
Duration and effectiveness of glucose-lowering regimens in the real world management of diabetes: Data from the Australian EXTEND45 Linked Cohort Study by Tamara K. Young, Carinna Hockham, Louisa Sukkar, Amy Kang, Min Jun, Celine Foote, Jannah Baker, Kris Rogers, Sophia Zoungas, Alan Cass, David Sullivan, Meg J. Jardine
Published 2023-09-01
Article -
7
A codesigned integrated kidney and diabetes model of care improves patient activation among patients from culturally and linguistically diverse backgrounds by Edward Zimbudzi, Clement Lo, Sanjeeva Ranasinha, Tim Usherwood, Kevan R. Polkinghorne, Gregory Fulcher, Martin Gallagher, Stephen Jan, Alan Cass, Rowan Walker, Grant Russell, Greg Johnson, Peter G. Kerr, Sophia Zoungas
Published 2023-12-01
Article -
8
STAREE-Mind Imaging Study: a randomised placebo-controlled trial of atorvastatin for prevention of cerebrovascular decline and neurodegeneration in older individuals by Sharon L Naismith, Craig S Anderson, Stephane Heritier, Michael O'Sullivan, Sophia Zoungas, Joanne Ryan, Ian H Harding, Simone Spark, Meng Law, Trevor T-J Chong, Zachary Flanagan, Richard McIntyre, Gary Egan
Published 2023-11-01
Article -
9
Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (ST... by Rory Wolfe, Christopher M Reid, Andrew Tonkin, John J McNeil, Mark Nelson, Sophia Zoungas, Stephanie A Ward, Stephen J Nicholls, Geoffrey Cloud, Ingrid Hopper, Andrea Curtis, Joanne Ryan, Lawrence Beilin, Anthony Wierzbicki, Simone Spark, Trevor T-J Chong, Alissia Kost
Published 2023-04-01
Article -
10
Socioeconomic status and diabetes technology use in youth with type 1 diabetes: a comparison of two funding models by Kate E. Lomax, Kate E. Lomax, Craig E. Taplin, Craig E. Taplin, Craig E. Taplin, Mary B. Abraham, Mary B. Abraham, Mary B. Abraham, Grant J. Smith, Aveni Haynes, Ella Zomer, Katrina L. Ellis, Helen Clapin, Sophia Zoungas, Alicia J. Jenkins, Alicia J. Jenkins, Jenny Harrington, Jenny Harrington, Martin I. de Bock, Timothy W. Jones, Timothy W. Jones, Timothy W. Jones, Elizabeth A. Davis, Elizabeth A. Davis, Elizabeth A. Davis
Published 2023-08-01
Article